The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Allstate Corp. The  (ALL) Trade Now »     Rate ALL  -  Discuss ALL  -  Add to Watch List         Graphic_subscribe

       Sector: Financial  >  Industry: Insurance (Prop. & Casualty)
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
32.0%
Top:
0.0%
Rate ALL:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

ALL: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

From the Blogosphere

Zacks Analyst Blog Highlights: Enzon, Merck, OSI Pharmaceuticals, Pfizer and Bank of America Corporation – Press Releases
Logo1
38%

For Immediate Release

Chicago, IL – November 11, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Enzon (ENZN), Merck (MRK), OSI Pharmaceuticals (OSIP), Pfizer (PFE) and Bank of America Corporation (BAC).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Tuesday’s Analyst Blog:

<><>Enzon Beats,...
By  StraightStocks   (-6.13%  risk: moderate)  11/11/09 Comment


Enzon Beats, Announces Sell-off – Analyst Blog
Logo1
38%

Enzon (ENZN) achieved break-even earnings during the third quarter of 2009, better than the Zacks Consensus Estimate of loss of 7 cents but below the year-ago earnings of 1 cent. The company reported revenues of $44.6 million, a decline of 9% compared to $48.8 million reported in the third quarter of 2008.

Enzon records revenues from three sources -- products, royalties and contract manufacturing. The three segments recorded a decline of 1%, 6% and 56%, respectively, compared to the year-ago period.

Enzon has four marketed products -- Oncaspar for the treatment of acute lymphoblastic leukemia...
By  StraightStocks   (-6.13%  risk: moderate)  11/10/09 Comment


Micromet Misses Estimates – Analyst Blog
Logo1
38%

Micromet’s (MITI) third-quarter loss per share came in at 22 cents, well below the Zacks Consensus Estimate of 14 cents and a loss of 15 cents in the prior-year period. The company reported revenues of $4 million, compared to $7 million in the third quarter of 2008. Micromet records revenues primarily in the form of reimbursements of expenses incurred by the company under different collaborative agreements. We believe current investor focus is more on the developments of the company’s portfolio rather than the financials.

<>Operating expenses during the quarter increased 28% year over year...
By  StraightStocks   (-6.13%  risk: moderate)  11/09/09 Comment


Allstate Reports In Line – Analyst Blog
Logo1
38%

Allstate Corporation’s (ALL) third quarter operating earnings of 99 cents per share were in line with the Zacks Consensus Estimate. This is in stark contrast to the operating loss of 35 cents in the year-ago quarter. Results for the quarter benefited primarily from a milder catastrophe environment, prudent capital management and strong liquidity. However, lower investment income and decrease in property-liability premiums did weigh on the results.

Primarily as a result of 77.6% year-over-year decrease in catastrophe losses, the company turned to a GAAP net income of $221 million or 41 cen...
By  StraightStocks   (-6.13%  risk: moderate)  11/05/09 Comment


Notable Analyst Rating Changes 10/12: BNI, ALU, KR, ALL, PCG Upgrade; SNDK, OXY, NOK, LMT, BIDU Downgrade
UPGRADES:Davenport upgrades Burlington Northern Santa Fe (NYSE: BNI) from Neutral to Buy. Societe Generale upgrades Alcatel-Lucent (NYSE: ALU) from Sell to Hold. J.P. Morgan upgrades Kroger (NYSE: KR) from Neutral to Overweight. Price target raises from $21 to $27. Atlantic Equities upgrades Allstate (NYSE: ALL) from Underweight to Neutral. Price target $34. Jefferies upgrades PG&E Corp (NYSE: PCG) from Hold to Buy. Price target increased from $43.50 to $46. For daily real-time Upgrades go to http://www.streetinsider.com/UpgradesDOWNGRADES:UBS downgrades SanDisk (Nasdaq: SNDK) from Neutral ...
By  Street Insider   (+0.33%  risk: moderate)  10/12/09 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
DRYS DryShips Inc.
KO The CocaCola Company
WFC Wells Fargo & Company
YHOO Yahoo! Inc
T AT&T Inc
NVDA NVIDIA Corp

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on ALL

Visit streetinsider.com


Discussion Wall + Add  
bpmiller1   (+165.09%  risk: conservative)
They all follow SPY - Heres a simple method I use for to gauge where a stock will go using SPY . SPY is the bandleader with more volume 2-3x than any other stock (except for...
+   4 replies


More Resources

Graphic_arrow1 About Allstate Corp. The - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch